Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2022-12-21 00:00:00 ET · period of report 2022-12-20 · accession 0001415889-22-012885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-21 | 2022-12-20 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $94.96 | +8,000 | 10.4K | +340% | +$759.7K |
| D | 2022-12-21 | 2022-12-20 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $274.05 | -8,000 | 2,353 | -77% | -$2.19M |
| D | 2022-12-21 | 2022-12-20 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $0.00 | -8,000 | 8,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-20 | M | A | 8,000 | $94.96 | 10,353 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-20 | D | D | 8,000 | $274.05 | 2,353 | D | — | — | |
| 3 | Derivative | Share Tracking Award | 2022-12-20 | M | D | 8,000 | $0.00 | 8,000 | D | $94.96 · 2015-03-14 to 2024-03-14 | 8,000 Common Stock | (F2) Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |